salud pública advierte médicos no deben aplicar fármaco gilenya o fingolimod
Published 6 years ago • 643 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
3:35
review of the safety, efficacy and tolerability of fingolimod- video abstract id 220817
-
15:09
progress report iii - andrás czébely-lénárt
-
11:40
progress report iii - ildikó szántó
-
2:21
clinical efficacy and safety of oral decitabine/cedazuridine in 133 patients
-
14:47
progress report iii - dóra koch
-
15:41
progress report iii - blanka rebeka bódy
-
11:16
progress report iii - tímea lázár
-
8:11
spirit of hope - a history of genzyme 1981-2012
-
1:41
guillain-barre syndrome in colombia up more than tenfold
-
2:20
cassia zarzuela, md, pediatrician at rush
-
3:37
sanofi – my child matters children care program in paraguay with renaci fundación
-
1:33
sanofi is becoming the leading digital healthcare platform | vivastories | vivatech
-
57:07
adaptive computing class 23 - balance - prof. carlos gershenson
-
12:40
progress report iii - istván baradács
-
8:56
los niveles de lyso-gb3 aumentan en esta patología y disminuyen con el tse
-
40:11
encontro scientia online: disease mechanisms in lama2-cmd: knowns and unknowns - ana rita carlos
-
2:53
anne beal, sanofi - patient engagement is not patient centricity
-
3:33
what does patient centricity mean at sanofi?